State KS
Clinical Trials in Kansas
Kansas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kansas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 108 actively recruiting studies with Kansas sites out of 108 registered in total. The busiest research areas in Kansas are Head and Neck Cancer, Prostate Cancer, Heart Failure. Leading sponsors running trials in the state include University of Kansas Medical Center, National Cancer Institute (NCI), Incyte Corporation. By stage, Kansas trials break down as Phase 1 (24), Phase 2 (33), Phase 3 (33), Phase 4 (3).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Kansas
Frequently Asked Questions — Clinical Trials in Kansas
How many clinical trials are currently recruiting in Kansas?
ClinicalMetric currently tracks 108 actively recruiting clinical trials with at least one location in Kansas. The total number of registered studies—including active but not currently enrolling trials—is 108. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kansas?
Kansas hosts clinical trials across a broad range of medical conditions, including Head and Neck Cancer, Prostate Cancer, Heart Failure, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kansas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kansas?
To join a clinical trial in Kansas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kansas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Kansas
NCT05919511 N/A
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Condition
cGVHD
Enrollment
1,500 pts
Location
United States
Sponsor
Incyte Corporation
NCT06859762 Phase 1
Recruiting
A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
630 pts
Location
United States, China
Sponsor
MediLink Therapeutics (Suzhou)
NCT06424288 Phase 3
Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps Peop...
Condition
Heart Failure
Enrollment
6,712 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT07753850 Phase 2
Recruiting
A Study of SL-325 in Crohn's Disease Patients
Condition
Crohn's Disease
Enrollment
232 pts
Location
United States
Sponsor
Shattuck Labs, Inc.
NCT06780670 Phase 2, Phase 3
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Pr...
Condition
Prostate Cancer
Enrollment
443 pts
Location
United States, Australia, Brazil
Sponsor
Novartis Pharmaceuticals
NCT04167696 Phase 1
Recruiting
Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome ...
Condition
Acute Myeloid Leukemia
Enrollment
27 pts
Location
United States, Belgium
Sponsor
Celyad Oncology SA
NCT05592626 Phase 1, Phase 2
Recruiting
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fu...
Condition
Advanced Solid Tumors
Enrollment
366 pts
Location
United States, Canada, France
Sponsor
Marengo Therapeutics, Inc.
NCT06556654 N/A
Recruiting
Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (RE...
Condition
Breast Reconstruction Surgery
Enrollment
180 pts
Location
United States
Sponsor
W.L.Gore & Associates
NCT06034327 N/A
Recruiting
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
Condition
Myopia
Enrollment
150 pts
Location
United States
Sponsor
SightGlass Vision, Inc.
NCT07197866 Phase 2
Recruiting
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple Syste...
Condition
Multiple System Atrophy
Enrollment
200 pts
Location
United States, France, Germany
Sponsor
Teva Branded Pharmaceutical Pr
NCT07215923 Phase 1
Recruiting
A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smoker...
Condition
Thromboangiitis Obliterans (Buerger's Disease)
Enrollment
15 pts
Location
United States
Sponsor
Antidote Therapeutics, Inc
NCT05918861 Phase 3
Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Rece...
Condition
Acute Coronary Syndrome
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
DalCor Pharmaceuticals
NCT03072927 N/A
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Condition
Lumbar Spinal Stenosis
Enrollment
8,000 pts
Location
United States
Sponsor
Stryker Instruments
NCT07546929 Phase 2
Recruiting
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Di...
Condition
Type 2 Diabetes
Enrollment
300 pts
Location
United States
Sponsor
Housey Healthcare ULC
NCT06710756 Phase 1, Phase 2
Recruiting
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Condition
Pancreatic Ductal Adenocarcinoma
Enrollment
112 pts
Location
United States
Sponsor
Perspective Therapeutics
NCT06919003 Phase 2
Recruiting
Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Inje...
Condition
Kidney Transplant
Enrollment
180 pts
Location
United States
Sponsor
National Institute of Allergy
NCT07415031 Phase 2
Recruiting
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated ...
Condition
Solid Tumors
Enrollment
170 pts
Location
United States, Australia, Belgium
Sponsor
Mirati Therapeutics Inc.
NCT06524544 Phase 3
Recruiting
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hzi...
Condition
Locally Advanced Urothelial Carcinoma
Enrollment
320 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07213973 Phase 2
Recruiting
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participant...
Condition
Hidradenitis Suppurativa (HS)
Enrollment
40 pts
Location
United States, Canada
Sponsor
Incyte Corporation
NCT04994756 N/A
Recruiting
Stroke Thrombectomy and Aneurysm Registry
Condition
Stroke
Enrollment
40,000 pts
Location
United States, Canada, Germany
Sponsor
Medical University of South Ca
NCT07729137 Phase 2
Recruiting
Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial ...
Condition
Corneal Edema
Enrollment
121 pts
Location
United States
Sponsor
Emmecell
NCT06080464 N/A
Recruiting
Clinician Satisfaction With the VERABAND™
Condition
Chronic Low-back Pain
Enrollment
360 pts
Location
United States
Sponsor
University of Michigan
NCT06779630 N/A
Recruiting
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary ...
Condition
Coronary Artery Disease
Enrollment
150 pts
Location
United States, Austria, France
Sponsor
Teleflex
NCT06638307 Phase 1
Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
Condition
Advanced Breast Cancer
Enrollment
240 pts
Location
United States, Spain
Sponsor
Stemline Therapeutics, Inc.
NCT05172245 Phase 1
Recruiting
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head...
Condition
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
46 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology